Show simple item record

dc.contributor.authorTun, Nini
dc.contributor.authorLondon, Nikolas
dc.contributor.authorKyaw, Moe Kyaw
dc.contributor.authorSmithuis, Frank
dc.contributor.authorFord, Nathan
dc.contributor.authorMargolis, Todd
dc.contributor.authorDrew, W Lawrence
dc.contributor.authorLewallen, Susan
dc.contributor.authorHeiden, David
dc.date.accessioned2012-04-24T17:49:57Z
dc.date.available2012-04-24T17:49:57Z
dc.date.issued2011-08-15
dc.identifier.citationAIDS 2011; 14:41en
dc.identifier.issn1758-2652
dc.identifier.pmid21843351
dc.identifier.doi10.1186/1758-2652-14-41
dc.identifier.urihttp://hdl.handle.net/10144/220371
dc.description.abstractCytomegalovirus retinitis is a neglected disease in resource-poor settings, in part because of the perceived complexity of care and because ophthalmologists are rarely accessible. In this paper, we describe a pilot programme of CMV retinitis management by non-ophthalmologists. The programme consists of systematic screening of all high-risk patients (CD4 <100 cells/mm3) by AIDS clinicians using indirect ophthalmoscopy, and treatment of all patients with active retinitis by intravitreal injection of ganciclovir. Prior to this programme, CMV retinitis was not routinely examined for, or treated, in Myanmar.
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urlhttp://www.jiasociety.org/content/14/1/41en
dc.rightsArchived with thanks to Journal of the International AIDS Societyen
dc.subject.meshAdulten
dc.subject.meshAntiviral Agentsen
dc.subject.meshCytomegalovirus Retinitisen
dc.subject.meshDeveloping Countriesen
dc.subject.meshFemaleen
dc.subject.meshGancicloviren
dc.subject.meshHIV Infectionsen
dc.subject.meshHumansen
dc.subject.meshIntravitreal Injectionsen
dc.subject.meshMaleen
dc.subject.meshMass Screeningen
dc.subject.meshMyanmaren
dc.subject.meshNeglected Diseasesen
dc.subject.meshPrimary Health Careen
dc.subject.meshRetrospective Studiesen
dc.subject.meshTreatment Outcomeen
dc.titleCMV retinitis screening and treatment in a resource-poor setting: three-year experience from a primary care HIV/AIDS programme in Myanmaren
dc.typeArticleen
dc.contributor.departmentMedical Action Myanmar, Yangon, Myanmar; Wills Eye Institute, Retina Service, Philadelphia, PA, USA; Médecins Sans Frontières OCA, Yangon, Myanmar; Médecins Sans Frontières, London, UK; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, South Africa; University of California San Francisco, San Francisco, CA, USA; Kilimanjaro Centre for Community Ophthalmology, Moishe, Tanzania; California Pacific Medical Center, San Francisco, CA, USA; Seva Foundation, Berkeley, CA, USA.en
dc.identifier.journalJournal of the International AIDS Societyen
refterms.dateFOA2019-03-04T09:44:07Z
html.description.abstractCytomegalovirus retinitis is a neglected disease in resource-poor settings, in part because of the perceived complexity of care and because ophthalmologists are rarely accessible. In this paper, we describe a pilot programme of CMV retinitis management by non-ophthalmologists. The programme consists of systematic screening of all high-risk patients (CD4 <100 cells/mm3) by AIDS clinicians using indirect ophthalmoscopy, and treatment of all patients with active retinitis by intravitreal injection of ganciclovir. Prior to this programme, CMV retinitis was not routinely examined for, or treated, in Myanmar.


Files in this item

Thumbnail
Name:
11815_Tun_CMV-retinitis-screen ...
Size:
238.4Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record